Business Context and Reporting Period
Company: Healthcare Services Group, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 1995
Business Overview: The Company provides healthcare services, including laundry, linen, and housekeeping services to long-term care facilities. Operations are funded through service agreements with clients, many of whom are funded by federal and state governmental agencies.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1995 | Six Months Ended June 30, 1994 |
|---|---|---|
| Revenues | $73,010,685 | $64,518,283 |
| Net Income | $1,826,132 | $3,273,047 |
| Earnings Per Share (Diluted) | $0.22 | $0.41 |
| Operating Cash Flow | $2,565,100 | ($349,511) |
| Cash and Equivalents (End of Period) | $14,001,423 | $6,672,397 |
| Working Capital | $51,639,115 | $46,146,376 |
| Current Ratio | 10.5 to 1 | 6.5 to 1 |
| Debt | No borrowings under $13M line of credit | N/A |
Margins: Cost of services provided as a percentage of revenue increased to 84.4% for the six-month period (from 83.8% in 1994). Selling, general, and administrative (SG&A) expenses increased to 8.6% of revenue (from 8.0% in 1994).
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 13.2% year-over-year for the six-month period, driven by a 21.1% increase from new client agreements and 3.0% from geographic expansion, partially offset by cancellations.
- Profitability Decline: Net income decreased 44.2% to $1.8 million. This decline is primarily attributable to a $2.4 million non-cash provision for estimated legal costs related to an SEC inquiry and other matters.
- Expense Increases: Cost of services rose due to increased labor costs and amortization of service agreements. SG&A expenses increased due to staffing expansion for regional divisions.
- Liquidity Improvement: Cash and cash equivalents increased by $2.77 million, and working capital improved by $5.5 million, despite cash outflows for accounts payable and receivables growth.
Guidance, Risks, and Contingencies
- SEC Inquiry and Legal Costs: The Company is subject to an ongoing non-public SEC investigation regarding financial statements and potential violations of federal securities laws. Additionally, the U.S. Attorney is investigating certain vendor payments made between 1988 and 1992. The Company has recorded a $2.4 million provision for estimated legal costs, with total anticipated costs ranging from $1.5 million to $3.5 million.
- Promissory Notes: The Company sold promissory notes receivable to its bank with recourse. As of June 30, 1995, $100,000 of 1991 notes remain outstanding. A reserve of $100,000 is maintained for contingent losses.
- Guarantees: The Company previously guaranteed loans for a client (TLC St. Petersburg, Inc.). These loans were paid in full in March 1995, and pledged certificates of deposit were released.
- Litigation Settlement: A class action settlement liability of $2.125 million was settled via the issuance of 180,851 shares of common stock on August 1, 1995.
- Outlook: Management anticipates significant additional legal costs. However, they believe existing cash, operating cash flow, and the $13 million credit line (with $8.3 million currently reduced by letters of credit and guarantees) are adequate for foreseeable needs.
Investor Verification Checklist
- Legal Provision Accuracy: Verify the sufficiency of the $2.4 million provision for SEC inquiry and related legal costs against the estimated range of $1.5M–$3.5M.
- Recourse Liability: Monitor the status of the $100,000 outstanding promissory notes sold with recourse to the bank.
- Revenue Quality: Assess the impact of government payment delays on accounts receivable aging and the conversion of receivables to promissory notes.
- Credit Line Availability: Confirm the remaining availability of the $13 million line of credit after accounting for standby letters of credit and guarantees.
- Share Dilution: Note the issuance of 180,851 shares for litigation settlement and potential future issuances for stock option plans approved by shareholders.